Published on in Vol 8 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55918, first published .
Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study

Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study

Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study

Journals

  1. Helmer P, Hottenrott S, Wienböker K, Brugger J, Stoppe C, Schmid B, Kranke P, Meybohm P, Sammeth M. Postoperative use of fitness trackers for continuous monitoring of vital signs: a survey of hospitalized patients. Journal of Clinical Monitoring and Computing 2025 View
  2. Mikhael J, Darlington D, Howell B, Hydren J, Hernandez T, Werner S, Iraca T, Arnett M, Gonzalez V, Peschin S, Balch A, Moran D, Young-Daniels R, Banjo O, Obeng G, Asiedu-Ayeh B, Kawuo S, Tukur A, Mohammed I, Obeng A, Csanádi M, Lew T, Choon-Quinones M. The benefits of telehealth in promoting equity in blood cancer care – results of a multi-stakeholder forum and systematic literature review. Journal of Medical Economics 2025;28(1):788 View
  3. Farhan S, Kennedy V, Espinoza-Gutarra M, Lust H, Bobillo M, Lin A, Olin R, Lin R, Rentscher K, Taylor M, Mohanraj L, Wood W, Murthy H, Ahmed N, Dueck A, Phelan R, Kelly D, Yuen C, Munshi P, Schoemans H, Hamilton B, Lee C, Sung A. Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT. Transplantation and Cellular Therapy 2025 View
  4. Youssef E, Weddle K, Zimmerman L, Palmer D. Pharmacovigilance in Cell and Gene Therapy: Evolving Challenges in Risk Management and Long-Term Follow-Up. Drug Safety 2025 View